Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2013 Oct 24;50(10):939–949. doi: 10.1007/s13312-013-0265-z

Recent advances in management of bronchiolitis

Nishant Verma 1, Rakesh Lodha 1, S K Kabra 1,2,✉
PMCID: PMC7097440  PMID: 24222284

Abstract

Background

Bronchiolitis is one of the major causes for hospital admissions in infants. Managing bronchiolitis, both in the outpatient and inpatient setting remains a challenge to the treating pediatrician. The effectiveness of various interventions used for infants with bronchiolitis remains unclear.

Need and purpose

To evaluate the evidence supporting the use of currently available treatment and preventive strategies for infants with bronchiolitis and to provide practical guidelines to the practitioners managing children with bronchiolitis.

Methods

A search of articles published on bronchiolitis was performed using PubMed. The areas of focus were diagnosis, treatment and prevention of bronchiolitis in children. Relevant information was extracted from English language studies published over the last 20 years. In addition, the Cochrane Database of Systematic Reviews was searched.

Results and Conclusions

Supportive care, comprising of taking care of oxygenation and hydration, remains the corner-stone of therapy in bronchiolitis. Pulse oximetry helps in guiding the need for oxygen administration. Several recent evidence-based reviews have suggested that bronchodilators or corticosteroids lack efficacy in bronchiolitis and should not be routinely used. A number of other novel therapies (such as nebulized hypertonic saline, heliox, CPAP, montelukast, surfactant, and inhaled furosemide) have been evaluated in clinical trials, and although most of them did not show any beneficial results, some like hypertonic saline, surfactant, CPAP have shown promising results.

Keywords: Bronchiolitis, CPAP, Epinephrine, Hypertonic saline, Surfactant

References

  • 1.American Academy of Pediatrics Subcommittee on DiagnosisManagement of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118:1774–1793. doi: 10.1542/peds.2006-2223. [DOI] [PubMed] [Google Scholar]
  • 2.Hanson IC, Shearer WT. Bronchiolitis. In: McMillan JA, Feigin RD, DeAngelis C, Jones MD, editors. Oski’s Pediatrics: Principles and Practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 1391. [Google Scholar]
  • 3.Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. The Tucson Children’s Respiratory Study II. Lower respiratory tract illness in the first year of life. Am J Epidemiol. 1989;129:1232–1264. doi: 10.1093/oxfordjournals.aje.a115243. [DOI] [PubMed] [Google Scholar]
  • 4.Gupta S, Shamsundar R, Shet A, Chawan R, Srinivasa H. Prevalence of respiratory syncytial virus infection among hospitalized children presenting with acute lower respiratory tract infections. Indian J Pediatr. 2011;78:1495–147. doi: 10.1007/s12098-011-0491-0. [DOI] [PubMed] [Google Scholar]
  • 5.Bharaj P, Sullender WM, Kabra SK, Mani K, Cherian J, Tyagi V, et al. Respiratory viral infections detected by multiplex PCR among pediatric patients with lower respiratory tract infections seen at an urban hospital in Delhi from 2005 to 2007. Virol J. 2009;26:89. doi: 10.1186/1743-422X-6-89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Maitreyi RS, Broor S, Kabra SK, Ghosh M, Seth P, Dar L, et al. Rapid detection of respiratory viruses by centrifugation enhanced cultures from children with acute lower respiratory tract infections. J Clin Virol. 2000;16:41–47. doi: 10.1016/S1386-6532(99)00075-X. [DOI] [PubMed] [Google Scholar]
  • 7.Banerjee S, Bharaj P, Sullender W, Kabra SK, Broor S. Human metapneumovirus infections among children with acute respiratory infections seen in a large referral hospital in India. J Clin Virol. 2007;38:70–72. doi: 10.1016/j.jcv.2006.07.003. [DOI] [PubMed] [Google Scholar]
  • 8.Bharaj P, Sullender WM, Kabra SK, Broor S. Human bocavirus infection in children with acute respiratory tract infection in India. J Med Virol. 2010;82:812–816. doi: 10.1002/jmv.21637. [DOI] [PubMed] [Google Scholar]
  • 9.Stempel HE, Martin ET, Kuypers J, Englund JA, Zerr DM. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr. 2009;98:123–126. doi: 10.1111/j.1651-2227.2008.01023.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zorc JJ, Hall CB. Bronchiolitis: Recent evidence on diagnosis and management. Pediatrics. 2010;125:342–349. doi: 10.1542/peds.2009-2092. [DOI] [PubMed] [Google Scholar]
  • 11.Canducci F, Debiaggi M, Sampaolo M, Marinozzi MC, Berrè S, Terulla C, et al. Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. J Med Virol. 2008;80:716–723. doi: 10.1002/jmv.21108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Milder E, Arnold JC. Human metapneumovirus and human bocavirus in children. Pediatr Res. 2009;65:78R–83R. doi: 10.1203/PDR.0b013e31819db90c. [DOI] [PubMed] [Google Scholar]
  • 13.Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Ed-wards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443–450. doi: 10.1056/NEJMoa025472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cherian T, Simoes EA, Steinhoff MC, Chitra K, John M, Raghupathy P, et al. Bronchiolitis in tropical South India. Am J Dis Child. 1990;144:1026–1030. doi: 10.1001/archpedi.1990.02150330086028. [DOI] [PubMed] [Google Scholar]
  • 15.Kneyber MC, Brandenburg AH, de Groot R, Joosten KF, Rothbarth PH, Ott A, et al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr. 1998;157:331–335. doi: 10.1007/s004310050822. [DOI] [PubMed] [Google Scholar]
  • 16.Swingler GH, Hussey GD, Zwarenstein M. Duration of illness in ambulatory children diagnosed with bronchiolitis. Arch Pediatr Adolesc Med. 2000;154:997–1000. doi: 10.1001/archpedi.154.10.997. [DOI] [PubMed] [Google Scholar]
  • 17.Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA. 1999;282:1440–1446. doi: 10.1001/jama.282.15.1440. [DOI] [PubMed] [Google Scholar]
  • 18.Shaw KN, Bell LM, Sherman NH. Outpatient assessment of infants with bronchiolitis. Am J Dis Child. 1991;145:151–155. doi: 10.1001/archpedi.1991.02160020041012. [DOI] [PubMed] [Google Scholar]
  • 19.Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126:212–219. doi: 10.1016/S0022-3476(95)70547-3. [DOI] [PubMed] [Google Scholar]
  • 20.Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J. 2003;22:S40–S44. doi: 10.1097/01.inf.0000053884.21238.13. [DOI] [PubMed] [Google Scholar]
  • 21.McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis. Am J Dis Child. 1986;140:806–812. doi: 10.1001/archpedi.1986.02140220088039. [DOI] [PubMed] [Google Scholar]
  • 22.Voets S, van Berlaer G, Hachimi-Idrissi S. Clinical predictors of the severity of bronchiolitis. Eur J Emerg Med. 2006;13:134–138. doi: 10.1097/01.mej.0000206194.85072.33. [DOI] [PubMed] [Google Scholar]
  • 23.Mansbach JM, Clark S, Christopher NC, LoVecchio F, Kunz S, Acholonu U, et al. Prospective multicenter study of bronchiolitis: predicting safe discharges from the emergency department. Pediatrics. 2008;121:680–688. doi: 10.1542/peds.2007-1418. [DOI] [PubMed] [Google Scholar]
  • 24.Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child. 2009;94:99–103. doi: 10.1136/adc.2008.139188. [DOI] [PubMed] [Google Scholar]
  • 25.Schuh S, Lalani A, Allen U, Manson D, Babyn P, Stephens D, et al. Evaluation of the utility of radiography in acute bronchiolitis. J Pediatr. 2007;150:429–433. doi: 10.1016/j.jpeds.2007.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Purcell K, Fergie J. Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2007;26:311–315. doi: 10.1097/01.inf.0000258627.23337.00. [DOI] [PubMed] [Google Scholar]
  • 27.Laham FR, Trott AA, Bennett BL, Kozinetz CA, Jewell AM, Garofalo RP, et al. LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity. Pediatrics. 2010;125:e225–233. doi: 10.1542/peds.2009-0411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ong GM, Wyatt DE, O’Neill HJ, McCaughey C, Coyle PV. A comparison of nested polymerase chain reaction and immunofluorescence for the diagnosis of respiratory in children with bronchiolitis. J Hosp Infect. 2001;49:122–128. doi: 10.1053/jhin.2001.1044. [DOI] [PubMed] [Google Scholar]
  • 29.Hguenin A, Moutte L, Renois F, Leveque N, Talmud D, Abely M, et al. Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system. J Med Virol. 2012;84:79–85. doi: 10.1002/jmv.23272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Reis AD, Fink MCD, Machado CM, Paz JP, Jr, Oliveira RR, Tateno AF, et al. Comparison of direct immunofluorescence, conventional cell culture and polymerase chain reaction techniques for detecting respiratory syncytial virus in nasopharyngeal aspirates from infants. Rev Inst Med Trop S Paulo. 2008;50:37–40. doi: 10.1590/s0036-46652008000100008. [DOI] [PubMed] [Google Scholar]
  • 31.Smyth RL, Openshaw PJ. Bronchiolitis. Lancet. 2006;368:312–322. doi: 10.1016/S0140-6736(06)69077-6. [DOI] [PubMed] [Google Scholar]
  • 32.van Steensel-Moll HA, Hazelzet JA, van der Voort E, Neijens HJ, Hackeng WH. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child. 1990;65:1237–1239. doi: 10.1136/adc.65.11.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Steiner RWP. Treating acute bronchiolitis associated with RSV. Am Family Physician. 2004;69:325–330. [PubMed] [Google Scholar]
  • 34.Schroeder AR, Marmor AK, Pantell RH, Newman TB. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med. 2004;158:527–530. doi: 10.1001/archpedi.158.6.527. [DOI] [PubMed] [Google Scholar]
  • 35.Unger S, Cunningham S. Effect of oxygen supplementation on length of stay for infants hospitalized with acute viral bronchiolitis. Pediatrics. 2008;121:470–475. doi: 10.1542/peds.2007-1135. [DOI] [PubMed] [Google Scholar]
  • 36.Donlan M, Fontela PS, Puligandla PS. Use of continuous positive airway pressure (CPAP) in acute viral bronchiolitis: A systematic review. Pediatr Pulmonol. 2011;46:736–746. doi: 10.1002/ppul.21483. [DOI] [PubMed] [Google Scholar]
  • 37.Smith TC, Marini JJ. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol. 1988;65:1488–1499. doi: 10.1152/jappl.1988.65.4.1488. [DOI] [PubMed] [Google Scholar]
  • 38.Milési C, Matecki S, Jaber S, Mura T, Jacquot A, Pidoux O, et al. 6 cm H2O continuous positive airway pressure versus conventional oxygen therapy in severe viral bronchiolitis: A randomized trial. Pediatr Pulmonol. 2013;48:45–51. doi: 10.1002/ppul.22533. [DOI] [PubMed] [Google Scholar]
  • 39.Essouri S, Durand P, Chevret L, Balu L, Devictor D, Fauroux B, et al. Optimal level of nasal continuous positive airway pressure in severe viral bronchiolitis. Intensive Care Med. 2011;37:2002–2007. doi: 10.1007/s00134-011-2372-4. [DOI] [PubMed] [Google Scholar]
  • 40.Wohl MEB. Bronchiolitis. In: Chernick V, Boat TF, Wilmott RW, Bush A, editors. Kendig’s Disorders of the Respiratory Tract in Children. 6th ed. Philadelphia: Saunders Elsevier Publishers; 1998. pp. 423–432. [Google Scholar]
  • 41.Roqué i Figuls M, Giné-Garriga M, Granados Rugeles C, Perrotta C. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2012;2:CD004873. doi: 10.1002/14651858.CD004873.pub4. [DOI] [PubMed] [Google Scholar]
  • 42.Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2010;12:CD001266. doi: 10.1002/14651858.CD001266.pub2. [DOI] [PubMed] [Google Scholar]
  • 43.Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011;6:CD003123. doi: 10.1002/14651858.CD003123.pub3. [DOI] [PubMed] [Google Scholar]
  • 44.Patel H, Gouin S, Platt RW. Randomized, double-blind, placebo-controlled trial of oral albuterol in infants with mild-to-moderate acute viral bronchiolitis. J Pediatr. 2003;142:509–514. doi: 10.1067/mpd.2003.196. [DOI] [PubMed] [Google Scholar]
  • 45.Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2010;10:CD004878. doi: 10.1002/14651858.CD004878.pub3. [DOI] [PubMed] [Google Scholar]
  • 46.Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: A systematic review and meta-analysis. Pediatr Crit Care Med. 2004;5:482–489. doi: 10.1097/01.PCC.0000128891.54799.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009;360:2079–2089. doi: 10.1056/NEJMoa0900544. [DOI] [PubMed] [Google Scholar]
  • 48.Blom DJM, Ermers M, Bont L, van Woensel JBM, van Aalderen WMC. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev. 2007;1:CD004881. doi: 10.1002/14651858.CD004881.pub2. [DOI] [PubMed] [Google Scholar]
  • 49.Ermers MJJ, Rovers MM, van Woensel JB, Kimpen JLL, Bont LJ, on behalf of the RSV Corticosteroid Study Group The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial. BMJ. 2009;338:b897. doi: 10.1136/bmj.b897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Davies HD, Matlow A, Petric M, Glazier R, Wang EE. Prospective comparative study of viral, bacterial and atypical organisms identified in pneumonia and bronchiolitis in hospitalized Canadian infants. Pediatr Infect Dis J. 1996;15:371–375. doi: 10.1097/00006454-199604000-00017. [DOI] [PubMed] [Google Scholar]
  • 51.Spurling GK, Doust J, Del Mar CB, Eriksson L. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2011;6:CD005189. doi: 10.1002/14651858.CD005189.pub3. [DOI] [PubMed] [Google Scholar]
  • 52.Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J. 2007;29:91–97. doi: 10.1183/09031936.00029206. [DOI] [PubMed] [Google Scholar]
  • 53.Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2008;4:CD006458. doi: 10.1002/14651858.CD006458.pub2. [DOI] [PubMed] [Google Scholar]
  • 54.Luo Z, Liu E, Luo J, Li S, Zeng F, Yang X, et al. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int. 2010;52:199–202. doi: 10.1111/j.1442-200X.2009.02941.x. [DOI] [PubMed] [Google Scholar]
  • 55.Anil AB, Anil M, Saglam AB, Cetin N, Bal A, Aksu N. High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis. Pediatr Pulmonol. 2010;45:41–47. doi: 10.1002/ppul.21108. [DOI] [PubMed] [Google Scholar]
  • 56.Bar A, Srugo I, Amirav I, Tzverling C, Naftali G, Kugelman A. Inhaled furosemide in hospitalized infants with viral bronchiolitis: A randomized, double-blind, placebo-controlled pilot study. Pediatr Pulmonol. 2008;43:261–267. doi: 10.1002/ppul.20765. [DOI] [PubMed] [Google Scholar]
  • 57.Umoren R, Odey F, Meremikwu MM. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age. Cochrane Database Syst Rev. 2011;1:CD006435. doi: 10.1002/14651858.CD006435.pub2. [DOI] [PubMed] [Google Scholar]
  • 58.Can D, Inan G, Yendur G, Oral R, Gunay I. Salbutamol or mist in acute bronchiolitis. Acta Paediatrica Japonica. 1998;40:252–255. doi: 10.1111/j.1442-200X.1998.tb01922.x. [DOI] [PubMed] [Google Scholar]
  • 59.Amirav I, Luder AS, Kruger N, Borovitch Y, Babai I, Miron D, et al. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. Pediatrics. 2008;122:e1249–e1255. doi: 10.1542/peds.2008-1744. [DOI] [PubMed] [Google Scholar]
  • 60.Zedan M, Gamil N, El-Assmy M, Fayez E, Nasef N, Fouda A, et al. Montelukast as an episodic modifier for acute viral bronchiolitis: a randomized trial. Allergy Asthma Proc. 2010;31:147–153. doi: 10.2500/aap.2010.31.3324. [DOI] [PubMed] [Google Scholar]
  • 61.Kim CK, Choi J, Kim HB, Callaway Z, Shin BM, Kim JT, et al. A randomized intervention of montelukast for postbronchiolitis: effect on eosinophil degranulation. J Pediatr. 2010;156:749–754. doi: 10.1016/j.jpeds.2009.12.001. [DOI] [PubMed] [Google Scholar]
  • 62.Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice MP, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008;178:854–860. doi: 10.1164/rccm.200706-910OC. [DOI] [PubMed] [Google Scholar]
  • 63.Liet JM, Ducruet T, Gupta V, Cambonie G. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev. 2010;4:CD006915. doi: 10.1002/14651858.CD006915.pub2. [DOI] [PubMed] [Google Scholar]
  • 64.Eber E. Treatment of acute viral bronchiolitis. Open Microbiol J. 2011;5:159–164. doi: 10.2174/1874285801105010159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN, et al. Pharmacologic treatment of bronchiolitis in infants and children. Arch Pediatr Adolesc Med. 2004;158:127–137. doi: 10.1001/archpedi.158.2.127. [DOI] [PubMed] [Google Scholar]
  • 66.Dunn MC, Knight DA, Waldman WJ. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide. Antivir Ther. 2011;16:309–317. doi: 10.3851/IMP1763. [DOI] [PubMed] [Google Scholar]
  • 67.Olszewska W, Ispas G, Schnoeller C, Sawant D, Van de Casteele T, Nauwelaers D, et al. Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model. Eur Respir J. 2011;38:401–408. doi: 10.1183/09031936.00005610. [DOI] [PubMed] [Google Scholar]
  • 68.Douglas JL, Panis ML, Ho E, Lin KY, Krawczyk SH, Grant DM, et al. Small Molecules VP-14637 and JNJ-2408068 Inhibit Respiratory Syncytial Virus Fusion by Similar Mechanisms. Antimicrobial Agents Chemoth. 2005;49:2460–2466. doi: 10.1128/AAC.49.6.2460-2466.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Deffrasnes C, Hamelin M, Prince GA, Boivin G. Identification and Evaluation of a Highly Effective Fusion Inhibitor for Human Metapneumovirus. Antimicrobial Agents Chemoth. 2008;52:279–287. doi: 10.1128/AAC.00793-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Jat KR, Chawla D. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev. 2012;9:CD009194. doi: 10.1002/14651858.CD009194.pub2. [DOI] [PubMed] [Google Scholar]
  • 71.Mejías A, Ramilo O. Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in highrisk infants. Biologics. 2008;2:433–439. doi: 10.2147/btt.s3104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Fuller HL, Del Mar CB. Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev. 2006;4:CD004883. doi: 10.1002/14651858.CD004883.pub2. [DOI] [PubMed] [Google Scholar]
  • 73.American Academy of Pediatrics. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006. [Google Scholar]
  • 74.American Academy of Pediatrics Committee on Infectious DiseasesCommittee on FetusNewborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1442–1446. doi: 10.1542/peds.112.6.1442. [DOI] [PubMed] [Google Scholar]

Articles from Indian Pediatrics are provided here courtesy of Nature Publishing Group

RESOURCES